CN Stock MarketDetailed Quotes
002349 Jinghua Pharmaceutical Group
- 8.10
- +0.02+0.25%
Market Closed Dec 19 15:00 CST
6.59BMarket Cap30.45P/E (TTM)
8.13High7.98Low136.26KlotVolume8.03Open8.08Pre Close109.75MTurnover1.67%Turnover Ratio26.64P/E (Static)814.18MShares9.3452wk High2.60P/B6.59BFloat Cap5.7952wk Low8.89Limit Up814.18MShs Float30.12Historical High7.27Limit Down1.86%Amplitude2.00Historical Low0.09Dividend TTM8.05Avg Price66.40KlotAsk1.14%Div YieldTTM100Lot Size68.11KlotBid
Jinghua Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.65%1.05B | -9.43%720.31M | -11.82%367.13M | -3.90%1.51B | -4.71%1.12B | 0.48%795.35M | 1.87%416.36M | 15.85%1.57B | 21.26%1.18B | 23.39%791.55M |
| Operating revenue | -6.65%1.05B | -9.43%720.31M | -11.82%367.13M | -3.90%1.51B | -4.71%1.12B | 0.48%795.35M | 1.87%416.36M | 15.85%1.57B | 21.26%1.18B | 23.39%791.55M |
| Other operating revenue | ---- | 40.25%11.26M | ---- | -31.75%15.41M | ---- | -10.72%8.03M | ---- | 5.46%22.58M | ---- | 23.59%8.99M |
| Total operating cost | -4.51%825.88M | -8.29%542.65M | -6.80%278.29M | -11.10%1.19B | -8.26%864.87M | -4.59%591.68M | -6.09%298.58M | 13.53%1.33B | 11.32%942.7M | 19.47%620.12M |
| Operating cost | -8.91%523.96M | -12.71%354.04M | -12.46%180.78M | -7.43%775.64M | -5.89%575.2M | -0.78%405.57M | 0.34%206.5M | 15.47%837.91M | 18.62%611.2M | 24.54%408.76M |
| Operating tax surcharges | -2.18%15.47M | -3.89%10.42M | -7.00%5.3M | -4.83%21.3M | -3.53%15.81M | 0.70%10.85M | 0.21%5.7M | 8.04%22.39M | 7.51%16.39M | 2.72%10.77M |
| Operating expense | 11.09%183.28M | 7.84%116.17M | 22.61%57.96M | -9.58%227.97M | -6.55%164.99M | 3.89%107.72M | -19.63%47.27M | 17.25%252.12M | 8.35%176.55M | 19.00%103.69M |
| Administration expense | 3.56%86.85M | 5.86%55.93M | 4.14%27.32M | -20.21%118.8M | -20.20%83.86M | -22.10%52.83M | -20.37%26.23M | 8.20%148.9M | 4.35%105.09M | 7.33%67.82M |
| Financial expense | -57.77%-30.83M | -87.75%-26.41M | -2,923.92%-10.18M | -53.84%-23.15M | -38.64%-19.54M | -195.05%-14.07M | -359.80%-336.55K | -2,842.24%-15.05M | -1,899.88%-14.09M | -792.27%-4.77M |
| -Interest expense (Financial expense) | 7.19%2.07M | 11.74%1.46M | -11.80%725.9K | -62.12%2.57M | -65.67%1.93M | -67.84%1.31M | -68.88%823.03K | -47.50%6.79M | -37.47%5.62M | -29.72%4.06M |
| -Interest Income (Financial expense) | -82.90%-33.68M | -117.09%-26.63M | -212.03%-10.04M | -55.09%-23.64M | -62.63%-18.42M | -99.43%-12.26M | -2.96%-3.22M | -7.60%-15.24M | -10.91%-11.32M | -7.03%-6.15M |
| Research and development | 5.85%47.15M | 12.95%32.51M | 29.47%17.11M | -25.71%64.62M | -6.33%44.54M | -14.96%28.78M | -10.61%13.22M | 16.35%86.98M | -10.85%47.56M | 15.37%33.84M |
| Credit Impairment Loss | -38.78%-2.02M | 12.48%-2.57M | 81.37%-423.21K | 61.23%-2.03M | 67.85%-1.46M | 39.07%-2.93M | 26.85%-2.27M | 59.29%-5.23M | 64.88%-4.53M | -2,643.63%-4.81M |
| Asset Impairment Loss | 71.41%-974.98K | 38.44%-1.26M | 120.35%297.88K | 65.72%-7.95M | 85.43%-3.41M | 67.85%-2.04M | 71.09%-1.46M | 18.85%-23.19M | -1,917.26%-23.41M | -364.56%-6.35M |
| Other net revenue | 326.98%9.65M | 692.60%7.32M | 455.31%7.06M | -63.17%4.3M | 136.64%2.26M | -117.69%-1.24M | -18.44%-1.99M | 487.08%11.67M | -125.35%-6.17M | -13.94%6.99M |
| Fair value change income | -28.36%3.66M | 21.15%3.41M | 216.42%2.87M | 36.89%6.83M | 26.50%5.11M | -8.36%2.81M | -44.22%905.98K | -84.45%4.99M | -86.95%4.04M | 645.15%3.07M |
| Invest income | 764.74%1.94M | 363.31%1.6M | 159.51%135.62K | -99.03%238.45K | -112.10%-292.45K | -147.23%-606.28K | -134.04%-227.9K | 3,771.78%24.46M | -32.05%2.42M | -51.28%1.28M |
| -Including: Investment income associates | -7.54%-661.26K | 93.94%-29.08K | 186.76%97.06K | ---1.26M | ---614.89K | ---479.8K | ---111.87K | ---- | ---- | ---- |
| Asset deal income | 104.21%3.15K | 105.35%3.15K | ---- | -46.89%-87.05K | -26.46%-74.94K | -17,139.42%-58.91K | 14,761.01%50.1K | 89.77%-59.26K | -7,172.68%-59.26K | -140.78%-341.73 |
| Other revenue | 194.89%7.04M | 286.76%6.14M | 309.45%4.18M | -31.81%7.29M | -84.48%2.39M | -88.49%1.59M | -75.69%1.02M | 41.56%10.7M | 293.53%15.38M | 298.87%13.79M |
| Operating profit | -10.94%228.94M | -8.62%184.98M | -17.18%95.9M | 31.56%330.85M | 13.66%257.05M | 13.46%202.43M | 29.96%115.79M | 39.32%251.48M | 54.35%226.16M | 36.67%178.41M |
| Add:Non operating Income | -72.00%226.02K | -78.55%173.94K | -95.17%20.39K | -40.38%1.09M | 341.48%807.32K | 4,411.04%811.1K | 54,461.01%422.03K | 604.08%1.82M | -40.44%182.87K | -92.30%17.98K |
| Less:Non operating expense | 361.02%3.95M | 5,233.55%2.63M | 18.02%51.11K | -27.42%2.25M | 75.82%857.51K | -61.97%49.24K | 13,301.49%43.31K | 64.89%3.09M | 159.07%487.73K | -28.35%129.49K |
| Total profit | -12.37%225.21M | -10.17%182.53M | -17.48%95.87M | 31.77%329.7M | 13.79%257M | 13.96%203.2M | 30.39%116.17M | 39.87%250.21M | 54.02%225.86M | 36.53%178.3M |
| Less:Income tax cost | -5.89%34.7M | -6.77%27.62M | -18.95%13.88M | 40.36%53.23M | 1.07%36.87M | 9.70%29.63M | 20.25%17.13M | -2.58%37.92M | 45.60%36.48M | 43.48%27.01M |
| Net profit | -13.46%190.51M | -10.75%154.91M | -17.22%81.98M | 30.23%276.47M | 16.24%220.13M | 14.72%173.56M | 32.31%99.04M | 51.68%212.29M | 55.75%189.38M | 35.36%151.29M |
| Net profit from continuing operation | -13.46%190.51M | -10.75%154.91M | -17.22%81.98M | 30.23%276.47M | 16.24%220.13M | 14.72%173.56M | 32.31%99.04M | 51.68%212.29M | 55.75%189.38M | 35.36%151.29M |
| Less:Minority Profit | 6.03%26.27M | 2.71%19.47M | -4.11%10.9M | 44,851.53%28.77M | 20.88%24.78M | -10.62%18.96M | 42.15%11.37M | 100.31%64K | 401.05%20.5M | 253.89%21.21M |
| Net profit of parent company owners | -15.93%164.23M | -12.40%135.43M | -18.92%71.08M | 16.71%247.7M | 15.68%195.35M | 18.85%154.61M | 31.14%87.67M | 32.06%212.23M | 31.52%168.88M | 22.98%130.08M |
| Earning per share | ||||||||||
| Basic earning per share | -15.92%0.2017 | -12.43%0.1663 | -18.94%0.0873 | 16.69%0.3042 | 15.67%0.2399 | 18.84%0.1899 | 31.18%0.1077 | 32.07%0.2607 | 31.52%0.2074 | 23.02%0.1598 |
| Diluted earning per share | -15.92%0.2017 | -12.43%0.1663 | -18.94%0.0873 | 16.69%0.3042 | 15.67%0.2399 | 18.84%0.1899 | 31.18%0.1077 | 32.07%0.2607 | 31.52%0.2074 | 23.02%0.1598 |
| Other composite income | -3.22M | |||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | ---3.22M | ---- | ---- | ---- | ---- | ---- | ---- |
| Total composite income | -13.46%190.51M | -10.75%154.91M | -17.22%81.98M | 28.71%273.24M | 16.24%220.13M | 14.72%173.56M | 32.31%99.04M | 51.68%212.29M | 55.75%189.38M | 35.36%151.29M |
| Total composite income of parent company owners | -15.93%164.23M | -12.40%135.43M | -18.92%71.08M | 15.20%244.47M | 15.68%195.35M | 18.85%154.61M | 31.14%87.67M | 32.06%212.23M | 31.52%168.88M | 22.98%130.08M |
| Total composite income of minority owners | 6.03%26.27M | 2.71%19.47M | -4.11%10.9M | 44,851.53%28.77M | 20.88%24.78M | -10.62%18.96M | 42.15%11.37M | 100.31%64K | 401.05%20.5M | 253.89%21.21M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
